Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Anticancer Research|October 28, 2020
Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell CarcinomaTakayuki Sugiyama, Seiiciro Ozono, Hideaki Miyake
Chemical & Pharmaceutical Bulletin|April 3, 2013
Synthesis of 2,3-bis(halomethyl)quinoxaline derivatives and evaluation of their antibacterial and antifungal activitiesHisato Ishikawa, Takayuki Sugiyama, Akihiro Yokoyama
In Vivo (Athens, Greece)|April 29, 2021
Assessment of Blood Plasma Free-amino Acid Levels in Infertile MenTakayuki Sugiyama, Hiroshi Terada, Hideaki Miyake
International Cancer Conference Journal|January 18, 2020
Complete response to combination therapy with nivolumab and ipilimumab for metastatic collecting duct carcinoma of the kidneyKyohei Watanabe, Takayuki Sugiyama, Atsushi Otsuka, et al.
Bioorganic Chemistry|January 17, 2012
Synthesis and antimicrobial activity of 2,3-bis(bromomethyl)quinoxaline derivativesHisato Ishikawa, Takayuki Sugiyama, Keisuke Kurita, et al.
International Cancer Conference Journal|March 31, 2021
Renal allograft rejection after treatment with nivolumab in patients with metastatic renal cell carcinomaGaku Ishikawa, Takayuki Sugiyama, Toshiki Ito, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 7, 2022
Comparison of perioperative outcomes among patients with exophytic, mesophytic, and endophytic renal tumors undergoing robot-assisted partial nephrectomyDaisuke Motoyama, Toshiki Ito, Takayuki Sugiyama, et al.
Cureus|January 12, 2026
Clinical Anthropometry in Male Infertility: Differences Between Men With and Without Klinefelter SyndromeRyo Sato, Takayuki Sugiyama, Rikiya Matsumoto, et al.
Medical Oncology (Northwood, London, England)|April 4, 2013
Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case studyTatsuya Takayama, Hiroshi Furuse, Fumitake Kai, et al.
Japanese Journal of Clinical Oncology|May 14, 2013
Axitinib controlled metastatic renal cell carcinoma for 5 yearsTatsuya Takayama, Masao Nagata, Fumitake Kai, et al.
Pageof 11